Cardiolinc™ is a non-profit international network focusing on new generation technologies to personalize diagnostics and treatment for cardiovascular patients. Its mission is to understand the role regulatory RNAs in cardiovascular disease and drive development and growth of personalized medicine by fostering interdisciplinary collaboration and public-private partnerships.
Cardiolinc™ connects scientists, clinicians and industry members worldwide from multiple disciplines, such as cardiology, genetics, molecular biology and computational sciences. It coordinates and eases the challenges of multidisciplinary collaboration, creating effective partnerships to translate discoveries in the laboratory into clinical applications.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 1 Rue Thomas Edison, Luxembourg,luxembourg 1445,luxembourg
- Industry
- Research
- Website
- cardiolinc.org
- Keywords
- Biomarker, Precision medicine, Public-private partnership, Translational medicine, Cardiovascular disease, non-coding RNA.
- HQ
- Luxembourg, Luxembourg
- Competitors
- YEAST4BIO COST Action 18229, Megeno, School of Information Technology, Artificial Intelligence and Cyber Security, ISCB RSG-Luxembourg, Fondation Jeunes Scientifiques Luxembourg, Luxembourg Institute of Health, Helix Space, ProSciens, computer-aided drug design, Beyourcells, Science Insights Luxembourg.
Cardiolinc Questions
Cardiolinc's website is cardiolinc.org
Cardiolinc's LinkedIn profile is https://lu.linkedin.com/company/cardiolinc
Cardiolinc has
1 employees.
View email and phone details for 1
employees at Cardiolinc.
Cardiolinc's industry is
Research
Cardiolinc's top competitors are
Yeast4bio Cost Action 18229,
Megeno,
School Of Information Technology, Artificial Intelligence And Cyber Security,
Iscb Rsg-Luxembourg,
Fondation Jeunes Scientifiques Luxembourg,
Luxembourg Institute Of Health,
Helix Space,
Prosciens, Computer-Aided Drug Design,
Beyourcells,
Science Insights Luxembourg.
Cardiolinc's categories are Research
Cardiolinc's founding year is 2014
